Alterity Therapeutics Ltd SEC filings ATHE

Alterity Therapeutics Ltd has 1,000 filings in SEC EDGAR's recent list, going back to Oct 22, 2007. Its latest annual report, Form 20-F, was filed on Aug 28, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Oct 30, 2026. The company's fiscal year ends on June 30.

Alterity Therapeutics Ltd SEC filings
Form Description Filed Period
20-F Annual report (foreign issuer) Aug 28, 2026 Jun 30, 2026
20-F Annual report (foreign issuer) Aug 29, 2025 Jun 30, 2025
20-F Annual report (foreign issuer) Sep 26, 2024 Jun 30, 2024
20-F Annual report (foreign issuer) Aug 31, 2023 Jun 30, 2023
20-F Annual report (foreign issuer) Aug 31, 2022 Jun 30, 2022
20-F Annual report (foreign issuer) Sep 2, 2021 Jun 30, 2021
20-F Annual report (foreign issuer) Sep 15, 2020 Jun 30, 2020
20-F Annual report (foreign issuer) Aug 30, 2019 Jun 30, 2019
20-F Annual report (foreign issuer) Aug 31, 2018 Jun 30, 2018
20-F Annual report (foreign issuer) Aug 31, 2017 Jun 30, 2017
20-F Annual report (foreign issuer) Oct 4, 2016 Jun 30, 2016
20-F Annual report (foreign issuer) Aug 26, 2015 Jun 30, 2015
20-F Annual report (foreign issuer) Nov 3, 2014 Jun 30, 2014
20-F Annual report (foreign issuer) Oct 22, 2013 Jun 30, 2013
20-F Annual report (foreign issuer) Oct 4, 2012 Jun 30, 2012
20-F Annual report (foreign issuer) Sep 30, 2011 Jun 30, 2011
20-F Annual report (foreign issuer) Nov 9, 2010 Jun 30, 2010
20-F Annual report (foreign issuer) Sep 24, 2009 Jun 30, 2009
20-F Annual report (foreign issuer) Sep 25, 2008 Jun 30, 2008

Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ATHE (Nasdaq), PRNAF (OTC)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
Melbourne
SEC filer status
Non-accelerated filer
SEC CIK
1131343
Former names
PRANA BIOTECHNOLOGY LTD (until Apr 8, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.